SI
IBB icon

Stephens Inc’s iShares Biotechnology ETF IBB Stock Holding History

Stephens Inc’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Buy
7,737
+283
+4% +$48.6K 0.02% 580
2026
Q1 		$1.26M Buy
7,454
+154
+2% +$26.3K 0.02% 583
2025
Q4 		$1.23M Buy
7,300
+1,988
+37% +$323K 0.02% 587
2025
Q3 		$767K Hold
5,312
– – 0.01% 717
2025
Q2 		$672K Buy
5,312
+471
+10% +$57.8K 0.01% 731
2025
Q1 		$619K Hold
4,841
– – 0.01% 742
2024
Q4 		$640K Sell
4,841
-85
-2% -$11.9K 0.01% 741
2024
Q3 		$717K Sell
4,926
-33
-0.7% -$4.78K 0.01% 701
2024
Q2 		$681K Sell
4,959
-1,745
-26% -$233K 0.01% 690
2024
Q1 		$920K Buy
6,704
+134
+2% +$18.3K 0.01% 601
2023
Q4 		$893K Sell
6,570
-641
-9% -$78.2K 0.02% 563
2023
Q3 		$882K Sell
7,211
-188
-3% -$23.9K 0.02% 550
2023
Q2 		$939K Sell
7,399
-302
-4% -$39.2K 0.02% 568
2023
Q1 		$995K Sell
7,701
-434
-5% -$56.8K 0.02% 535
2022
Q4 		$1.07M Buy
8,135
+1,649
+25% +$213K 0.02% 489
2022
Q3 		$759K Sell
6,486
-862
-12% -$107K 0.02% 581
2022
Q2 		$864K Sell
7,348
-1,166
-14% -$138K 0.02% 564
2022
Q1 		$1.11M Sell
8,514
-12,708
-60% -$1.66M 0.02% 566
2021
Q4 		$3.24M Sell
21,222
-6,017
-22% -$932K 0.05% 353
2021
Q3 		$4.4M Sell
27,239
-1,304
-5% -$219K 0.07% 293
2021
Q2 		$4.67M Sell
28,543
-17,346
-38% -$2.67M 0.07% 282
2021
Q1 		$6.91M Buy
45,889
+2,066
+5% +$328K 0.11% 188
2020
Q4 		$6.64M Buy
43,823
+2,826
+7% +$404K 0.12% 182
2020
Q3 		$5.55M Sell
40,997
-295
-0.7% -$40K 0.11% 188
2020
Q2 		$5.64M Buy
41,292
+19,307
+88% +$2.46M 0.12% 179
2020
Q1 		$2.37M Buy
21,985
+2,268
+12% +$261K 0.06% 310
2019
Q4 		$2.38M Buy
19,717
+2,095
+12% +$234K 0.05% 362
2019
Q3 		$1.75M Sell
17,622
-150
-0.8% -$15.7K 0.04% 418
2019
Q2 		$1.94M Buy
17,772
+1,131
+7% +$120K 0.04% 412
2019
Q1 		$1.86M Sell
16,641
-1,252
-7% -$137K 0.04% 410
2018
Q4 		$1.73M Sell
17,893
-2,245
-11% -$238K 0.05% 394
2018
Q3 		$2.46M Buy
20,138
+5,917
+42% +$697K 0.06% 353
2018
Q2 		$1.56M Sell
14,221
-233
-2% -$24.9K 0.05% 379
2018
Q1 		$1.54M Buy
14,454
+1,156
+9% +$128K 0.06% 320
2017
Q4 		$1.42M Buy
13,298
+1,262
+10% +$135K 0.05% 324
2017
Q3 		$1.34M Buy
12,036
+2,706
+29% +$289K 0.05% 330
2017
Q2 		$964K Buy
9,330
+1,146
+14% +$113K 0.03% 443
2017
Q1 		$800K Buy
8,184
+3,498
+75% +$335K 0.03% 464
2016
Q4 		$415K Sell
4,686
-21,000
-82% -$1.91M 0.02% 540
2016
Q3 		$2.48M Buy
25,686
+4,710
+22% +$448K 0.11% 207
2016
Q2 		$1.8M Buy
20,976
+17,721
+544% +$1.59M 0.08% 258
2016
Q1 		$283K Sell
3,255
-1,527
-32% -$137K 0.01% 556
2015
Q4 		$539K Sell
4,782
-3,192
-40% -$346K 0.03% 432
2015
Q3 		$806K Sell
7,974
-87
-1% -$10.4K 0.04% 366
2015
Q2 		$991K Buy
8,061
+2,226
+38% +$266K 0.05% 365
2015
Q1 		$668K Buy
5,835
+15
+0.3% +$1.65K 0.03% 445
2014
Q4 		$588K Buy
5,820
+1,551
+36% +$151K 0.03% 470
2014
Q3 		$389K Sell
4,269
-1,704
-29% -$150K 0.02% 550
2014
Q2 		$512K Sell
5,973
-2,820
-32% -$222K 0.03% 499
2014
Q1 		$693K Sell
8,793
-120
-1% -$10K 0.04% 396
2013
Q4 		$675K Sell
8,913
-378
-4% -$26.8K 0.03% 432
2013
Q3 		$649K Buy
9,291
+540
+6% +$35.4K 0.04% 410
2013
Q2 		$507K Buy
+8,751
New +$506K 0.03% 425

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Stephens Inc's IBB Position: Q2 2026 in Review

Stephens Inc increased its iShares Biotechnology ETF (IBB) stake by 3.8% in Q2 2026, buying an estimated $48.6K and bringing the position to 7,737 shares worth $1.47M. The position accounts for 0.02% of the portfolio, ranked #580.

Stephens Inc first reported a position in IBB in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.91M in Q1 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Stephens Inc held 7,737 shares of iShares Biotechnology ETF worth $1.47M as of Q2 2026.
  • Stephens Inc bought 283 iShares Biotechnology ETF shares in Q2 2026, an estimated $48.6K.
  • iShares Biotechnology ETF made up 0.02% of Stephens Inc's portfolio in Q2 2026, its #580 holding.
  • Stephens Inc first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 53 quarters since.
  • Stephens Inc's iShares Biotechnology ETF position peaked at $6.91M in Q1 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.